The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Description

Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research

Conditions

Hematologic Diseases

Talk to us

Study Overview

On this page

Study Details

Study overview

Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Condition
Hematologic Diseases
Intervention / Treatment

-

Contacts and Locations

San Diego

LabPMM, San Diego, California, United States, 92121

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and/or formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens/samples have been sent to LabPMM for clinical testing
  • 2. Donor Age ≥ 18 years
  • 1. Sample/specimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM
  • 2. The specimens/samples have previously been enrolled in a clinical study

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Invivoscribe, Inc.,

Study Record Dates

2027-06-30